MAPK14 Antikörper (Tyr322)
Kurzübersicht für MAPK14 Antikörper (Tyr322) (ABIN2306355)
Target
Alle MAPK14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Tyr322
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- MAP Kinase 14 (Tyr322) (Mitogen-activated Protein Kinase 14, MAPK 14, MAPK14, Mitogen-activated Protein Kinase p38alpha, MAP Kinase p38alpha, Cytokine Suppressive Anti-inflammatory Drug binding Protein, CSAID Binding Protein, CSBP, MAX-interacting Protein 2, MAP Kinase MXI2, SAPK2A)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic non-phosphopeptide corresponding to amino acid residues surrounding Y322 of human MAPK14 (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- MAPK14 (Mitogen-Activated Protein Kinase 14 (MAPK14))
-
Andere Bezeichnung
- MAP Kinase 14
-
NCBI Accession
- NP_620581
-
UniProt
- Q16539
-
Pathways
- MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Hepatitis C, Toll-Like Receptors Cascades, Autophagie, Thromboxane A2 Receptor Signaling, BCR Signaling, S100 Proteine
Target
-